Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,121 | -6,112 | -4,017 | -1,638 | 8,015 |
| Depreciation Amortization | 10 | 8 | 5 | 2 | 296 |
| Accounts receivable | -6 | -45 | -28 | -22 | 106 |
| Accounts payable and accrued liabilities | 472 | 464 | 421 | 171 | -1,302 |
| Other Working Capital | 663 | 492 | 303 | -20 | -1,395 |
| Other Operating Activity | 4,361 | 3,253 | 2,081 | 841 | -11,823 |
| Operating Cash Flow | $-2,621 | $-1,939 | $-1,235 | $-666 | $-6,104 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -614 | -636 | -617 | N/A | N/A |
| PPE Investments | N/A | N/A | N/A | N/A | -1 |
| Purchase Of Investment | -345 | -357 | -347 | N/A | N/A |
| Other Investing Activity | 138 | 147 | 70 | 0 | 5,278 |
| Investing Cash Flow | $-822 | $-846 | $-894 | $N/A | $5,277 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 112 | 274 |
| Common Stock Repurchased | 1,483 | 1,429 | 943 | N/A | N/A |
| Other Financing Activity | -54 | -44 | -37 | -3 | -154 |
| Financing Cash Flow | $1,429 | $1,385 | $906 | $109 | $119 |
| Exchange Rate Effect | -43 | -42 | -39 | -17 | 113 |
| Beginning Cash Position | 4,034 | 4,176 | 4,051 | 3,717 | 4,391 |
| End Cash Position | 1,978 | 2,733 | 2,789 | 3,143 | 3,796 |
| Net Cash Flow | $-2,056 | $-1,443 | $-1,262 | $-574 | $-595 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,621 | -1,939 | -1,235 | -666 | -6,104 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -1 |
| Free Cash Flow | -2,621 | -1,939 | -1,235 | -666 | -6,105 |